Strategies for design and application of enteric viral vaccines.
Enteric viral infections in domestic animals cause significant economic losses. The recent emergence of virulent enteric coronaviruses [porcine epidemic diarrhea virus (PEDV)] in North America and Asia, for which no vaccines are available, remains a challenge for the global swine industry. Vaccination strategies against rotavirus and coronavirus (transmissible gastroenteritis virus) infections are reviewed. These vaccination principles are applicable against emerging enteric infections such as PEDV. Maternal vaccines to induce lactogenic immunity, and their transmission to suckling neonates via colostrum and milk, are critical for early passive protection. Subsequently, in weaned animals, oral vaccines incorporating novel mucosal adjuvants (e.g., vitamin A, probiotics) may provide active protection when maternal immunity wanes. Understanding intestinal and systemic immune responses to experimental rotavirus and transmissible gastroenteritis virus vaccines and infection in pigs provides a basis and model for the development of safe and effective vaccines for young animals and children against established and emerging enteric infections.
Canadian Food Inspection Agency, Lethbridge, Alberta T1H 6P7, Canada; email: kuldeep.chattha@inspection.gc.ca.
Kuldeep S
KS
Chattha
James A
JA
Roth
Linda J
LJ
Saif
D000818:Animals; D000831:Animals, Newborn; D017934:Coronavirus / Q000276:immunology; D018352:Coronavirus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D007112:Immunity, Maternally-Acquired; D007410:Intestinal Diseases / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D058751:Livestock; D012401:Rotavirus / Q000276:immunology; D012400:Rotavirus Infections / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D013552:Swine / Q000821:virology*; D013553:Swine Diseases / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000379:methods; D014765:Viral Vaccines
D014765:Viral Vaccines
gut–mammary gland–sIgA axis; lactogenic immunity; mucosal adjuvants; porcine epidemic diarrhea virus; rotavirus; transmissible gastroenteritis virus